Optimising Particle Size Control with Avestin High-Pressure Homogenisation

In the exacting world of biopharmaceutical manufacturing, particle size distribution (PSD) is more than just a metric; it is a fundamental determinant of product efficacy, stability, and regulatory compliance. From liposomal vaccines to nano-emulsions, the ability to maintain a narrow and reproducible PSD is central to achieving predictable pharmacokinetics and mitigating risks like aggregation or sedimentation. For lab professionals across the UK and Ireland, Biopharma Group provides an industry-leading solution to these challenges through the Avestin EmulsiFlex range.

High-pressure homogenisation (HPH) stands out as a best practice method for size reduction, utilising rapid acceleration, shear, and cavitation to fragment particles into uniform dimensions. This process is critical for transforming multilamellar liposomes into uniform unilamellar structures and creating nano-suspensions with droplet sizes below 200 nm. Beyond size reduction, Avestin systems excel in mechanical cell lysis, allowing for the efficient recovery of intracellular contents without the need for chemical reagents.

Seamless Scalability: From R&D to Full-Scale Production 

One of the most significant hurdles in formulation design is ensuring that results achieved in the laboratory can be replicated at pilot and manufacturing scales. Avestin’s EmulsiFlex range directly addresses the "scale-up gap" by employing a unique design philosophy: geometrically matched flow paths and identical homogenising valve designs across their entire equipment lineup.

Unlike systems that require complete process re-validation when moving to larger volumes, Avestin systems ensure that the energy dissipation and flow dynamics remain constant. This means that a Particle Size Distribution (PSD) optimised on a benchtop unit like the EmulsiFlex-B15 is directly reproducible on a high-capacity production model. For the lab professional, this eliminates the guesswork and reduces the time-to-market by ensuring process predictability at every stage of development.

Precision Control and Thermal Reliability 

To ensure product integrity, especially for heat-sensitive biologics and delicate lipid formulations, precision is paramount. The Avestin range features sophisticated thermal management systems, including high-efficiency heat exchangers that allow for strict temperature control during the high-energy homogenisation process. This prevents the degradation of active ingredients that can occur due to the heat generated by friction and pressure.

Furthermore, the adjustable valve geometry allows operators to fine-tune flow patterns with extreme accuracy. By precisely regulating pressure, users can balance the intensity of the shear forces against the stability of the product. This level of control ensures that even the most complex formulations achieve the desired characteristics without compromising the molecular integrity of the API.

As the exclusive distributor for Avestin in the UK and Ireland, Biopharma Group provides the technical expertise and local support necessary to ensure your bioprocessing applications meet the highest standards of quality.

To discuss your requirements and find a model most suited to your needs, contact Biopharma Group’s product specialists.